Astellas Pharma
4503.T
$9.47
Share price
-1.51%
Change (1 day)
-36.95%
Change (1 year)
Categories
Astellas Pharma (4503.T) - P/B ratio
P/B ratio as of April 2024 : 1.62
According to Astellas Pharma's latest financial reports the company has a price-to-book ratio of 1.62.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Astellas Pharma - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.01 | -11.81% |
| 2022-12-31 | 2.28 | -3.38% |
| 2021-12-31 | 2.36 | 9.26% |
| 2020-12-31 | 2.16 | -18.38% |
| 2019-12-31 | 2.65 | 27.14% |
| 2018-12-31 | 2.08 | -1.5% |
| 2017-12-31 | 2.12 | -17.13% |
| 2016-12-31 | 2.55 | -9.5% |
| 2015-12-31 | 2.82 | 4.23% |
| 2014-12-31 | 2.71 | 14.57% |
| 2013-12-31 | 2.36 | 38.8% |
| 2012-12-31 | 1.70 | 18.02% |
| 2011-12-31 | 1.44 | 3.14% |
| 2010-12-31 | 1.40 | -14.89% |
| 2009-12-31 | 1.64 |